Jennifer Peppe - Aug 16, 2022 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Role
Global Head, Clinical Operations
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Jennifer Peppe
Stock symbol
IMGO
Transactions as of
Aug 16, 2022
Transactions value $
-$108,147
Form type
4
Date filed
8/17/2022, 05:05 PM
Previous filing
Aug 16, 2022
Next filing
Nov 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $16.1K +6.4K +4.3% $2.52* 155K Aug 16, 2022 Direct F1
transaction IMGO Common Stock Sale -$124K -6.4K -4.12% $19.41 149K Aug 16, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -6.4K -9.86% $0.00 58.6K Aug 16, 2022 Common Stock 6.4K $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $19.40 to $19.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Global Head, Clinical Operations